InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Shiff Susan Ph.D., Director. Officer active across 1 companies, notably Cara Therapeutics, Inc.. In total, 3 reports have been logged. The latest transaction was disclosed on 2 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
011,876 shares0
Common Stock
SEC:0001209191-22-034627:0·
07,200 shares0
Common Stock
SEC:0001209191-21-038765·
07,200 shares0
Common Stock
SEC:0001209191-21-038765:0·
3 of 3 declarations
About Shiff Susan Ph.D.
Susan Ph.D. Shiff is a Board Member of Cara Therapeutics, Inc. She brings expertise in research and development in the pharmaceutical field. Her role involves overseeing the company's research initiatives, which focus on pain management treatments.
